Trial
NCT02810483
Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Prader-Willi Syndrome
Intervention
Topiramate
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-11